| 2016 |
EHBP1L1 directly binds GTP-loaded Rab8 and Bin1/amphiphysin II, forming a complex with dynamin at the endocytic recycling compartment (ERC). This complex is required for apical-directed transport in polarized epithelial cells; EHBP1L1- or Bin1-depleted or dynamin-inhibited small intestine organoids accumulate apical membrane proteins in lysosomes. EHBP1L1-deficient mice display truncated and sparse microvilli, confirming its role in maintaining the apical plasma membrane. |
Biochemical pulldown, Co-IP, overexpression and knockdown in organoids, EHBP1L1-knockout mouse analysis, immunofluorescence |
The Journal of cell biology |
High |
26833786
|
| 2018 |
EHBP1L1 acts as a downstream effector of LRRK2-phosphorylated Rab8 and Rab10 on stressed lysosomes. LRRK2-mediated phosphorylation of Rab8/Rab10 recruits EHBP1L1 (and EHBP1) to overloaded lysosomes, where they mediate suppression of lysosomal enlargement and promotion of lysosomal secretion. |
Family-wide Rab GTPase screening, phosphorylation-dependent recruitment assays, lysosomal stress model (chloroquine), LRRK2-deficient mouse renal tubule analysis, immunofluorescence |
Proceedings of the National Academy of Sciences of the United States of America |
High |
30209220
|
| 2020 |
LRRK2-mediated phosphorylation of Rab10 blocks EHBP1L1-mediated recycling tubules and cargo turnover at macropinosomes in macrophages. EHBP1L1 overexpression competitively inhibits LRRK2 phosphorylation of Rab10 and promotes cargo recycling, mimicking LRRK2 kinase inhibition. Thus EHBP1L1 functions as an effector of non-phosphorylated (GTP-bound) Rab10 to drive fast vesicle recycling from macropinosomes. |
Overexpression competition assay, LRRK2 kinase inhibition, Rab10 knockdown, live-cell imaging of recycling tubules in mouse and human primary macrophages/dendritic cells/microglia-like cells |
The EMBO journal |
High |
32853409
|
| 2023 |
EHBP1L1 interacts with and stabilizes JAK1 protein in renal cell carcinoma cells. By competing with SOCS1, EHBP1L1 protects JAK1 from proteasomal degradation, elevating JAK1 levels and activating JAK1/STAT1/PD-L1 signaling to create an immunosuppressive tumor microenvironment. EHBP1L1 depletion reduces JAK1 protein, PD-L1 surface expression, and enhances CD8+ T cell-mediated anti-tumor immunity. |
Co-immunoprecipitation (EHBP1L1–JAK1 interaction), competitive binding assay with SOCS1, proteasomal degradation assay, EHBP1L1 knockdown/knockout with functional immune readouts, PDX models |
Advanced science (Weinheim, Baden-Wurttemberg, Germany) |
Medium |
36775874
|
| 2023 |
EHBP1L1 is required for nuclear polarization during erythroblast enucleation. Ehbp1l1-/- mice show impaired nuclear polarization before enucleation, leading to decreased enucleation efficiency, stomatocytic erythrocyte morphology with dehydration, and early postnatal anemic lethality. EHBP1L1 interactors Rab10, Bin1, and dynamin are also involved in this process, extending the Rab8/10-EHBP1L1-Bin1-dynamin axis to erythropoiesis. EHBP1L1 loss also causes mislocalization of nuclei and mitochondria in skeletal muscle cells, phenocopying centronuclear myopathy. |
Ehbp1l1-knockout mouse analysis, immunofluorescence for nuclear/organelle positioning, erythrocyte morphology and dehydration assays |
Blood advances |
High |
37042948
|
| 2023 |
EHBP1L1 and its newly identified interactors CD2AP and CIN85 negatively regulate primary cilia length via actin network remodeling around the basal body. EHBP1L1 is localized to the ciliary sheath and is required for CD2AP/CIN85 localization there. Depletion of EHBP1L1 or CD2AP/CIN85 causes cilia elongation and actin nucleation/branching defects at the ciliary base. A CD2AP/CIN85-binding-deficient EHBP1L1 mutant fails to rescue these phenotypes, demonstrating that the EHBP1L1–CD2AP/CIN85 interaction is mechanistically required. |
Immunofluorescence microscopy, siRNA knockdown, rescue with WT vs. binding-deficient EHBP1L1 mutant, cilia length measurements, actin organization assays |
The Journal of biological chemistry |
High |
36754282
|
| 2023 |
In colorectal cancer cells, PD-L1 membrane distribution is mediated by the membrane transport complex Rab8/EHBP1L1, placing EHBP1L1 in a PCSK6/ACVR1B-p300-Rab8/EHBP1L1-PD-L1 signaling axis that controls PD-L1 surface levels. |
Single-cell sequencing, co-immunoprecipitation, functional rescue/inhibition in tumor cell lines and mouse models |
Cell death and differentiation |
Low |
41975069
|
| 2010 |
EHBP1L1 (also known as Tangerin) contains a singlet calponin homology (CH) domain capable of actin binding, placing it in the class of multidomain proteins that link actin cytoskeletal organization to vesicular trafficking. |
Bioinformatic domain analysis (SMART program) and comparative sequence analysis of human singlet CH-domain proteins |
Molecular biology reports |
Low |
19459066
|
| 2020 |
EHBP1L1 was identified as a TBC1D1-interacting protein in C2C12 myotubes via quantitative proteomics. The interaction occurs through the phosphotyrosine binding (PTB) domains of TBC1D1 and is not regulated by AMPK activation. |
Unbiased quantitative proteomics Co-IP in C2C12 myotubes, AMPK activation experiments |
Scientific reports |
Medium |
33087848
|
| 2025 |
S1443 phosphorylation on EHBP1L1 is insulin-responsive in skeletal muscle of aged rats of both sexes, and this phosphosite is associated with insulin-stimulated glucose uptake specifically in females, suggesting EHBP1L1 participates in insulin/GLUT4 trafficking regulation via phosphorylation. |
Deep phosphoproteomic profiling of rat skeletal muscle with insulin stimulation and calorie restriction interventions |
The journals of gerontology. Series A, Biological sciences and medical sciences |
Low |
41105193
|
| 2022 |
EHBP1L1 is expressed in rat primary and secondary spermatocytes and localizes with actin in the perinuclear cytoplasm adjacent to the acrosomal and Golgi regions of spermatids during acrosome biogenesis, consistent with a role in vesicular trafficking during this process. |
Western blot, immunofluorescence, in situ hybridization, RT-PCR on enriched testicular cell fractions |
Biomedicines |
Low |
35052860
|